FSMDX
Price
$43.16
Change
-$0.13 (-0.30%)
Updated
Sep 4 closing price
Net Assets
53.11B
VYMRX
Price
$15.29
Change
+$0.11 (+0.72%)
Updated
Sep 3 closing price
Net Assets
140.66M
Interact to see
Advertisement

FSMDX vs VYMRX

FSMDX vs VYMRX Comparison Chart in %
View a ticker or compare two or three
VS
FSMDX vs. VYMRX commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Hold and VYMRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 53.1B vs. VYMRX (141M). FSMDX pays higher dividends than VYMRX: FSMDX (0.75) vs VYMRX (0.30). FSMDX was incepted earlier than VYMRX: FSMDX (15 years) vs VYMRX (28 years). VYMRX (1.57) is less costly to investors than FSMDX (0.03). VYMRX is a more actively managed with annual turnover of: 72.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than VYMRX: FSMDX (0) vs VYMRX (1000). FSMDX annual gain was more profitable for investors over the last year : 18.34 vs. VYMRX (-11.40). FSMDX return over 5 years is better than : 41.51 vs. VYMRX (-22.97).
FSMDXVYMRXFSMDX / VYMRX
Total Expense Ratio0.031.452%
Annual Report Gross Expense Ratio0.031.572%
Fund Existence15 years28 years-
Gain YTD17.22217.220100%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets53.1B141M37,660%
Annual Yield % from dividends0.750.30250%
Returns for 1 year18.34-11.40-161%
Returns for 3 years59.68-0.85-7,010%
Returns for 5 years41.51-22.97-181%
Returns for 10 years165.936.072,735%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSGZX144.822.32
+1.63%
Columbia Seligman Global Tech Inst
RMFCX64.340.28
+0.44%
American Funds American Mutual R-3
OSTFX21.43N/A
N/A
Osterweis
GENIX17.31N/A
N/A
Gotham Enhanced Return Institutional
FTMCX24.24N/A
N/A
First Trust Multi-Strategy Cl C